Teva shareholders elect four directors, approve say-on-pay and auditor at annual meeting

TEVA PHARMACEUTICAL INDUSTRIES LTD

Elected Prof. Varda Shalev to board through 2026; Rosemary Crane, Gerald Lieberman, Prof. Ronit Satchi-Fainaro through 2027.
Non-binding advisory vote on executive compensation approved: 571,822,049 for vs 120,609,632 against.
Shareholders recommended annual advisory vote on exec comp (one-year frequency) with 536,980,720 votes.
Ratification of Kesselman & Kesselman (PwC) as independent auditor approved: 731,150,255 for, 30,335,560 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.